ARCOSCREEN
ArcoScreen is a Swiss medtech is developing a new microfluidic discovery platform for drug screening targeting cell membrane receptors.
ARCOSCREEN
Social Links:
Industry:
Biopharma Biotechnology
Founded:
2021-07-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.arcoscreen.ch
Total Employee:
1+
Status:
Active
Contact:
(+41) 078 209 61 48
Email Addresses:
[email protected]
Total Funding:
300 K CHF
Technology used in webpage:
U.S. Server Location
Similar Organizations
Enterin
Philadelphia-based biotechnology company .
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Krystal Biotech
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Employees Featured
Founder
Investors List
Foundation for Technological Innovation (FIT)
Foundation for Technological Innovation (FIT) investment in Debt Financing - ArcoScreen
Venture Kick
Venture Kick investment in Grant - ArcoScreen
Official Site Inspections
http://www.arcoscreen.ch
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "ArcoScreen"
ArcoScreen GPCR screening
Arcoscreen’s mission is to help pharmaceutical companies identify promising G protein Coupled Receptor (GPCR) drugs in primary cells to get faster from research to clinical trials.See details»
Arcoscreen GPCR screening on primary cells — Arcoscreen
ArcoScreen provides a novel G protein coupled receptor screening platform directly performed on primary cells. Our GPCR assay is performed in a proprietary 384 microfluidic well-plate.See details»
arcoscreen - LinkedIn
Arcoscreen Biotechnology Research Lausanne, Vaud 1,232 followers Improve drug development to change patients' life.See details»
ArcoScreen - Crunchbase Company Profile & Funding
ArcoScreen is a Swiss medtech is developing a new microfluidic discovery platform for drug screening targeting cell membrane receptors.See details»
ArcoScreen SA Company Profile | Lausanne, VAUD, Switzerland ...
ArcoScreen SA Company Profile | Lausanne, VAUD, Switzerland | Competitors, Financials & Contacts - Dun & BradstreetSee details»
ArcoScreen SA - top100startup.ch
Dec 15, 2021 ArcoScreen SA: ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug discovery. Our revolutionary …See details»
ArcoScreen SA - BioAlps
ArcoScreen aims to change how we discover new drugs: their drug discovery solutions are performed directly on patient cells, helping to find treatments for diseases such as cancer or Alzheimer’s. ArcoScreen improves the go-to …See details»
Services — Arcoscreen
ArcoScreen offers a complete package for stable cell line development utilizing CHO-TRex or HEK-TRex cells. The time consuming and strenuous process will be handled by our team of experts to develop the inducible stable cell lines …See details»
ArcoScreen SA - Venture Kick
ArcoScreen SA: ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug …See details»
ArcoScreen: The Venture Leader Medtech facilitating accurate, …
May 23, 2022 ArcoScreen’s novel and unique patented assay is embedded in a microfluidic chip, called ArcoFlow, and provides a first-of-its-kind method for rapidly and accurately identifying …See details»
Contact — Arcoscreen
Contact E [email protected] Arcoscreen SA Chemin de la Raye 13 1024 Ecublens • SwitzerlandSee details»
ArcoScreen SA - Venture Kick
Mar 10, 2023 ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug …See details»
Startups Revolutionizing G Protein Coupled Receptors Screening ...
Aug 24, 2020 ArcoScreen: revolutionizing G protein coupled receptors screening G protein coupled receptors (GPCRs) are the most successful drug targets to treat diseases like cancer, …See details»
ArcoScreen wins CHF 150,000 to revolutionize drug discovery
Aug 26, 2021 ArcoScreen was founded in 2021 in Lausanne by Margaux Duchamp (CEO) and Thamani Dahoun (CTO). The Venture Kick funds will enable the startup to complete its team …See details»
ArcoScreen SA - Venture Kick
ArcoScreen SA, spin-off of EPFL (Ecole Polytechnique Fédérale de Lausanne), was founded in July 2021 and has developed a new cell membrane receptor screening platform based on …See details»
Technology — Arcoscreen
Our microfluidic technology: accelerates the assay (20 min), decrease the amount of reagents needed (2 uL volume chamber), standardizes the entire assay (integration of the microfluidics …See details»
ArcoScreen awarded CHF 1Mio Lopez-Loreta Prize to enable the …
Oct 14, 2021 ArcoScreen SA, an EPFL spinoff and Venture Kick Alumni developing novel drug screening tools, announced today that its co-founder Dr. Margaux Duchamp has been …See details»
ArcoScreen - EU-Startups
You're a corporate or investor and looking for startups that are innovating in the same market as ArcoScreen? We're happy to assist you with our Startup Sourcing service.See details»
ArcoScreen SA - Venturelab
Dec 7, 2021 ArcoScreen SA: ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors …See details»
ArcoScreen wins CHF 150,000 to revolutionize drug discovery
Aug 25, 2021 Lausanne-based EPFL spin-off ArcoScreen develops a novel assay for drug development, which enables savings of up to five years and USD 2.45 billion while providing …See details»